All trans-retinoic acid (ATRA) elevated eukaryotic translation initiation factor 4A1 (eIF4A1) mRNA in ATRA-responsive vitiliginous epidermis

Pigment Cell Research

Volumn 17, Issue 6, 2004, Pages 659-667

  Lee, Ai Young ^a,b   Kim, Nan Hyung ^a   Park, Seung Won ^a  

^a Eulji University School of Medicine   (South Korea)

^b Eulji General Hospital   (South Korea)

Author keywords

All trans retinoic acid; Eukaryotic translation initiation factor 4A1; Favorable clinical response; Vitiligo

Indexed keywords

COMPLEMENTARY DNA; INITIATION FACTOR; INITIATION FACTOR 4A1; MESSENGER RNA; PHOSPHOPROTEIN; RETINOIC ACID; RIBOSOME PROTEIN; RIBOSOME PROTEIN L13; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; HUMAN; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VITILIGO; WESTERN BLOTTING;

ADULT; AGED; BASE SEQUENCE; BIOLOGICAL MARKERS; DNA, COMPLEMENTARY; DRUG RESISTANCE; EPIDERMIS; EUKARYOTIC INITIATION FACTOR-4A; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRETINOIN; VITILIGO;

ATRA; EUKARYOTA;

EID: 9244234431     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2004.00186.x     Document Type: Article

References (38)

1. Lesnik RH, Mezick JA, Capetola R, Kligman LH. Topical all-trans-retinoic acid prevents corticosteroid-induced skin atrophy without abrogating the anti-inflammatory effect. J Am Acad Dermatol 1989;21:186-190
2. De Lacharriere O, Escoffier C, Gracia AM, Teillac D, Saint Leger D, Berrebi C, Debure A, Leveque JL, Kreis H, De Prost Y. Reversal effects of topical retinoic acid on the skin of kidney transplant recipients under systemic corticotherapy. J Invest Dermatol 1990;95:516-522
3. Kligman LH, Schwartz E, Lesnik RH, Mezick JA. Topical tretinoin prevents corticosteroid-induced atrophy without lessening the anti-inflammatory effect. Curr Probl Dermatol 1993;21:79-88
4. Norris DA, Kissinger PM, Naughton GM, Bystryn JC. Evidence for immunologic mechanism in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol 1988;90:781-789
5. Yu HS, Kao CH, Yu CL. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo. J Invest Dermatol 1993;100:823-828
6. Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 1995;154:450-458
7. Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, Ohno M, Funauchi M, Kanamaru A. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice. J Immunol 2003;170:5793-5798
8. Ortonne JP. Retinoic acid and pigment cells: a review of in-vitro and in-vivo studies. Br J Dermatol 1992;127 (Suppl. 41):43-47
9. Fligiel SEG, Imman DR, Talwar HS, Fisher GJ, Voorhees JJ, Varani J. Modulation of growth in normal and malignant melanocytic cells by all-trans-retinoic acid. J Cutan Pathol 1992;19:27-33
10. Yoshimura K, Tsukamoto K, Okazaki M, Virador VM, Lei TC, Suzuki Y, Uchida G, Kitano Y, Harii K. Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. J Dermatol Sci 2001;27 (Suppl. 1):S68-S75
11. Romero C, Aberdam E, Larnier C, Ortonne JP. Retinoic acid as modulator of UVB-induced melanocyte differentiation: involvement of the melanogenic enzymes expression. J Cell Sci 1994;107:1095-1103
12. Sanquer S, Reenstra WR, Eller MS, Gilchrest BA. Keratinocytes and dermal factors activate CRABP-I in melanocytes. Exp Dermatol 1998;7:369-379
13. Welsh BM, Mason RS, Halliday GM. Topical all-trans retinoic acid augments ultraviolet radiation-induced increases in activated melanocyte numbers in mice. J Invest Dermatol 1999;112:271-278
14. Lee A-Y, Youm Y-H, Kim N-H, Yang H, Choi W-I. Keratinocytes in the depigmented epidermis of vitiligo are more vulnerable to trauma (suction) than keratinocytes in the normally pigmented epidermis, resulting in their apoptosis. Br J Dermatol 2004;in press.
15. Gibbs S, Backendorf C, Ponec M. Regulation of keratinocyte proliferation and differentiation by all-trans-retinoic acid, 9-cis-retinoic acid and 1,25-dihydroxy vitamin D3. Arch Dermatol Res 1996;288:729-738
16. Stoll SW, Elder JT. Retinoid regulation of heparin-binding EGF-like growth factor gene expression in human keratinocytes and skin. Exp Dermatol 1998;7:391-397
17. Kim YJ, Kwak CI, Gu YY, Hwang IT, Chun JY. Annealing control primer system for identification of differentially expressed genes on agarose gels. Biotechniques 2004;36:424-426, 428, 430
18. Boyce ST, Ham RG. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 1983;81 (Suppl. 1): 33s-40s
19. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, Zeeberg B, Buetow KH, Schaefer CF, Bhat NK, Hopkins RF, Jordan H, Moore T, Max SI, Wang J, Hsieh F, Diatchenko L, Marusina K, Farmer AA, Rubin GM, Hong L, Stapleton M, Scares MB, Bonaldo MF, Casavant TL, Scheetz TE, Brownstein MJ, Usdin TB, Toshiyuki S, Carninci P, Prange C, Raha SS, Loquellano NA, Peters GJ, Abramson RD, Mullahy SJ, Bosak SA, McEwan PJ, McKernan KJ, Malek JA, Gunaratne PH, Richards S, Worley KC, Hale S, Garcia AM, Gay LJ, Hulyk SW, Villalon DK, Muzny DM, Sodergren EJ, Lu X, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madan A, Young AC, Shevchenko Y, Bouffard GG, Blakesley RW, Touchman JW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Krzywinski MI, Skalska U, Smailus DE, Schnerch A, Schein JE, Jones SJ, Marra MA. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A 2002;99:16899-16903
20. Casp CB, She JX, McCormack WT. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002;15:62-66
21. Spritz R, Fain P, Bennett D. IL-36 the epidemiology and genetics of generalized vitiligo. Pigment Cell Res 2003;16:589-590
22. Jin SY, Park HH, Li GZ, Lee HJ, Hong MS, Hong SJ, Park HK, Chung JH, Lee MH. Association of angiotensin converting enzyme gene I/D polymorphism of vitiligo in Korean population. Pigment Cell Res 2004;17:84-86
23. Eckhart L, Bach J, Ban J, Tschachler E. Melanin binds reversibly to thermostable DNA polymerase and inhibits its activity. Biochem Biophys Res Commun 2000;271:726-730
24. Rhoads RE. Cap recognition and the entry of mRNA into the protein synthesis initiation cycle. Trends Biochem Sci 1988;13:52-56
25. Sonenberg N. Cap-binding proteins of eukaryotic messenger RNA: functions in initiation and control of translation. Prog Nucleic Acid Res Mol Biol 1988;35:173-207
26. Edery I, Humbelin M, Darveau A, Lee KA, Milburn S, Hershey JW, Trachsel H, Sonenberg N. Involvement of eukaryotic initiation factor 4A in the cap recognition process. J Biol Chem 1983;258:11398-11403
27. Grifo JA, Tahara SM, Morgan MA, Shatkin AJ, Merrick WC. New initiation factor activity required for globin mRNA translation. J Biol Chem 1983;258:5804-5810
28. Tahara SM, Morgan MA, Shatkin AJ. Two forms of purified m7G-cap binding protein with different effects on capped mRNA translation in extracts of uninfected and poliovirus-infected HeLa cells. J Biol Chem 1981;256:7691-7694
29. Grifo JA, Abramson RD, Sailer CA, Merrick WC. RNA-stimulated ATPase activity of eukaryotic initiation factors. J Biol Chem 1984;259:8648-8654
30. Rozen F, Edery I, Meerovitch K, Dever TE, Merrick WC, Sonenberg N. Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F. Mol Cell Biol 1990;10:1134-1144
31. Tuazon PT, Morley SJ, Dever TE, Merrick WC, Rhoads RE, Traugh JA. Association of initiation factor eIF-4E in a cap binding protein complex (eIF-4F) is critical for and enhances phosphorylation by protein kinase C. J Biol Chem 1990;265:10617-10621
32. Aloni R, Peleg D, Meyuhas O. Selective translational control and nonspecific posttranscriptional regulation of ribosomal protein gene expression during development and regeneration of rat liver. Mol Cell Biol 1992;12:2202-2212
33. Huang S, Hershey JW. Translational initiation factor expression and ribosomal protein gene expression are repressed coordinately but by different mechanisms in murine lymphosarcoma cells treated with glucocorticoids. Mol Cell Biol 1989;9:3679-3684
34. Williams-Hill DM, Duncan RF, Nielsen PJ, Tahara SM. Differential expression of the murine eukaryotic translation initiation factor isogenes eIF4A1 and eIF4A2 is dependent upon cellular growth status. Arch Biocehm Biophys 1997;338:111-120
35. Eberle J, Krasagakis K, Orfanos CE. Translation initiation factor eIF4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer 1997;71:396-401
36. Eberle J, pecker LF, Bittner JU, Orfanos CE, Geilen CC. Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF4A1. Br J Cancer 2002;86:1957-1962
37. Lankat-Buttgereit B, Gregel C, Knolle A, Hasilik A, Arnold R, Goke R. Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II. Mol Cell Endocrinol 2004;214:149-153
38. Jansen AP, Camalier CE, Stark C, Colburn NH. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 2004;3:103-110